The age-related decline in circulating GH (growth hormone) levels in men is interpreted both as a symptom of neuroendocrine aging (as one of the causes of altered body composition and other unwelcomed symptoms of aging) and as a mechanism of natural protection from cancer and other chronic diseases. The gene discussed is GH1; the disease is cancer.